Virtu KCG Holdings’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Virtu KCG Holdings’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,750	Closed	-$475K	–	4144
2015 Q1	$475K	Buy	2,750 +457	+20%	+$67.1K	0.01%	1420
2014 Q4	$264K	Sell	2,293 -14,901	-87%	-$1.81M	﹤0.01%	2507
2014 Q3	$2.68M	Buy	17,194 +11,628	+209%	+$1.69M	0.05%	319
2014 Q2	$686K	Sell	5,566 -5,615	-50%	-$621K	0.01%	1593
2014 Q1	$1.16M	Buy	+11,181	New	+$1.14M	0.01%	1112
2013 Q4	–	Sell	-5,319	Closed	-$356K	–	4570
2013 Q3	$356K	Buy	+5,319	New	+$367K	﹤0.01%	2418

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Virtu KCG Holdings's SLXP Position: Q2 2015 in Review

Virtu KCG Holdings sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,750 shares — an estimated $475K sold.

Virtu KCG Holdings first reported a position in SLXP in Q3 2013 and held it in 6 quarters. The position peaked at $2.68M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Virtu KCG Holdings reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Virtu KCG Holdings sold 2,750 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $475K.
Virtu KCG Holdings first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 6 quarters.
Virtu KCG Holdings's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.68M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Virtu KCG Holdings's 13F filing for Q2 2015, filed 13 Aug 2015.